Recently Featured

Esperion to acquire Corstasis for cardiovascular franchise expansion

March 16, 2026
Esperion is set to acquire Corstasis Therapeutics in a strategic move to enhance its cardiovascular franchise through the addition of Enbumyst, a bumetanide nasal spray. This acquisition underscores Esperion’s commitment to expanding its portfolio in the cardiovascular space, particularly as the demand for innovative treatment options continues to rise. The integration of Enbumyst into Esperion’s…

Extracellular Vesicles: The Next Frontier in Regenerative Medicine and Drug Delivery

March 15, 2026
Recent advancements in the understanding of extracellular vesicles (EVs) highlight their potential to revolutionize regenerative medicine and drug delivery systems. These nanoscale membrane-bound particles, which facilitate intercellular communication, have emerged as key players in various biological processes, including tissue repair and immune responses. With their ability to transport proteins, lipids, and RNAs, EVs offer a…

Navigating uncertainty and building resilient supply chains: The case for US-based CDMO partnerships

March 15, 2026
Pharmaceutical companies are increasingly recognizing the strategic advantages of partnering with US-based Contract Development and Manufacturing Organizations (CDMOs) amidst a landscape of supply chain uncertainties. As global disruptions continue to challenge the pharmaceutical sector, US-based CDMOs offer not only localized manufacturing capabilities but also enhanced compliance with regulatory standards, which is critical in maintaining product…

UnitedHealth Reduces Subsidiary Disclosures Amid Promises of Transparency

March 15, 2026
Amid financial and reputational turmoil, top executives at UnitedHealth Group have promised to bring more transparency. A new reporting policy from the health care giant is doing the opposite. This week, UnitedHealth listed just 10 subsidiaries in its annual report, filed with the Securities and Exchange Commission. A year ago, the company disclosed nearly 3,100.…

Ongoing Cases